[144] Hamilton Insurance Group, Ltd. SEC Filing
Hamilton Insurance Group, Ltd. (HG) notice reports a proposed sale of 47,000 common shares through Morgan Stanley Smith Barney on 09/05/2025, with an aggregate market value of $1,145,413.50. The shares represent restricted stock units acquired from the issuer on 11/14/2023, and total shares outstanding are listed as 65,606,760. The filer indicates no related sales in the past three months and provides the standard representation that they are unaware of undisclosed material adverse information. Several filer and issuer identifying fields are not populated in the provided content.
- Full disclosure of transaction specifics: share count (47,000), acquisition date (11/14/2023), sale date (09/05/2025), broker, and aggregate market value ($1,145,413.50) are provided
- No sales in prior three months, simplifying aggregation rules under Rule 144
- Filer and issuer identifying fields are not populated in the provided content, reducing traceability
- Materiality is limited: the shares represent a small percentage (~0.072%) of reported outstanding shares, indicating the sale is likely routine rather than material
Insights
TL;DR Routine insider sale filing: 47,000 RSU-derived shares proposed for sale, modest relative to outstanding shares.
This Form 144 documents a planned sale of restricted stock units vested on 11/14/2023 totaling 47,000 shares with an aggregate market value of $1,145,413.50 to be executed via Morgan Stanley on 09/05/2025. As presented, the transaction appears procedural rather than a material capital-markets event because the shares equal ~0.072% of reported outstanding shares (47,000 of 65,606,760). The filing includes the required declaration that no undisclosed material adverse information is known. Missing filer/issuer contact fields reduce traceability but do not change the transaction particulars.
TL;DR Compliance filing meets Rule 144 disclosure elements but omits some identifying contact fields.
The form discloses acquisition as restricted stock units and lists broker, planned sale date, and market value, satisfying core Rule 144 notice content. The absence of filer CIK/CCC and issuer contact details in the provided excerpt may reflect redaction or incomplete extraction; the filing still contains the seller's representation about lack of undisclosed material adverse information and notes no sales in the prior three months. From a compliance perspective, ensure the complete submission includes all required identification to avoid administrative follow-up.